Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells With Primary Trastuzumab Resistance
Anti-Cancer Agents in Medicinal Chemistry - United Arab Emirates
doi 10.2174/187152012799015002
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2012
Authors
Publisher
Bentham Science Publishers Ltd.